Breast Cancer

Papers
(The TQCC of Breast Cancer is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis112
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status87
Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives60
A machine learning-based radiomics model for the prediction of axillary lymph-node metastasis in breast cancer46
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition42
Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions34
Axillary surgery for breast cancer: past, present, and future32
Annual report of the Japanese Breast Cancer Registry for 201729
The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast28
Prognostic values of clinical and molecular features in HER2 low-breast cancer with hormonal receptor overexpression: features of HER2-low breast cancer28
The dynamic change of neutrophil to lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients27
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer26
Circular RNAs serve as miRNA sponges in breast cancer26
Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer26
Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors26
Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis25
Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer25
Unmet needs in breast cancer survivors are common, and multidisciplinary care is underutilised: the Survivorship Needs Assessment Project24
Effects of yoga on improving quality of life in patients with breast cancer: a meta-analysis of randomized controlled trials23
Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC)23
Immune-related biomarkers in triple-negative breast cancer23
Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells22
Chemotherapy-related cognitive impairment in patients with breast cancer based on MRS and DTI analysis21
Annual report of the Japanese Breast Cancer Society registry for 201621
Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells20
Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis20
Resistance training in breast cancer patients undergoing primary treatment: a systematic review and meta-regression of exercise dosage20
Human umbilical cord mesenchymal stem cell-derived exosomes inhibit migration and invasion of breast cancer cells via miR-21-5p/ZNF367 pathway20
Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review19
CD1a- and CD83-positive dendritic cells as prognostic markers of metastasis development in early breast cancer patients19
Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis19
Effect of Apatinib plus melatonin on vasculogenic mimicry formation by cancer stem cells from breast cancer cell line19
Overall assessment system of combined mammography and ultrasound for breast cancer screening in Japan19
Profilin 2 (PFN2) promotes the proliferation, migration, invasion and epithelial-to-mesenchymal transition of triple negative breast cancer cells18
Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration18
A systematic review of behaviour change techniques used in interventions to increase physical activity among breast cancer survivors17
Negative impact of the COVID-19 state of emergency on breast cancer screening participation in Japan17
The association between MRI findings and breast cancer subtypes: focused on the combination patterns on diffusion-weighted and T2-weighted images16
PI3K/AKT and MAPK1 molecular changes preceding matrix metallopeptidases overexpression during tamoxifen-resistance development are correlated to poor prognosis in breast cancer patients16
Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes16
The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy16
Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms15
Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency15
Discriminating low-grade ductal carcinoma in situ (DCIS) from non-low-grade DCIS or DCIS upgraded to invasive carcinoma: effective texture features on ultrafast dynamic contrast-enhanced magnetic reso14
Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis14
Impact of artificial intelligence in breast cancer screening with mammography13
Obesity-related protein biomarkers for predicting breast cancer risk: an overview of systematic reviews13
Rac1 activation in human breast carcinoma as a prognostic factor associated with therapeutic resistance12
Effects of a personal trainer-led exercise intervention on physical activity, physical function, and quality of life of breast cancer survivors12
Fibromatosis of the breast: a 10-year multi-institutional experience and review of the literature12
Decreased ER dependency after acquired resistance to CDK4/6 inhibitors12
Association between dietary phytochemical index and breast cancer: a case–control study12
Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer12
Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand11
Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years +11
Breast-conserving surgery with intraoperative radiotherapy in recurrent breast cancer: the patient’s perspective11
XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis11
Fertility under uncertainty: exploring differences in fertility-related concerns and psychosocial aspects between breast cancer survivors and non-cancer infertile women11
Taste alterations in patients with breast cancer following chemotherapy: a cohort study11
miR-484 suppresses endocrine therapy-resistant cells by inhibiting KLF4-induced cancer stem cells in estrogen receptor-positive cancers11
Nipple-sparing mastectomy for breast cancer close to the nipple: a single institution’s 11-year experience11
Mapping the cancer-specific FACT-B onto the generic SF-6Dv211
Prevalence of germline TP53 variants among early-onset breast cancer patients from Polish population10
Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan10
Interleukin-34 contributes to poor prognosis in triple-negative breast cancer10
Microsurgical techniques in the treatment of breast cancer-related lymphedema: a systematic review of efficacy and patient outcomes10
Novel module and hub genes of distinctive breast cancer associated fibroblasts identified by weighted gene co‐expression network analysis10
Isoforms of IDH in breast carcinoma: IDH2 as a potent prognostic factor associated with proliferation in estrogen-receptor positive cases10
The transverse musculocutaneous gracilis flap for autologous breast reconstruction: focus on donor site morbidity10
Non-invasive quantitative measures of qualitative grading effectiveness as the indices of acute radiation dermatitis in breast cancer patients10
The safety of performing breast reconstruction during the COVID-19 pandemic9
Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 20189
Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report9
SNORA71B promotes breast cancer cells across blood–brain barrier by inducing epithelial-mesenchymal transition9
Quercetin: a silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT19
Germline variants of Brazilian women with breast cancer and detection of a novel pathogenic ATM deletion in early-onset breast cancer9
Development and biological assessment of MMAE-trastuzumab antibody–drug conjugates (ADCs)9
Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan9
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospect9
Integrative review of breast cancer survivors’ transition experience and transitional care: dialog with transition theory perspectives9
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced brea9
The effect of preoperative depression and anxiety on heart rate variability in women with breast cancer9
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer 9
Breast cancer populations may have an increased prevalence of thyroglobulin antibody and thyroid peroxidase antibody: a systematic review and meta-analysis9
Sexuality in breast cancer survivors: sexual experiences, emotions, and cognitions in a group of women under hormonal therapy9
Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review9
The role of adjuvant radiotherapy in patients with malignant phyllodes tumor of the breast: a propensity-score matching analysis9
Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER2-positive breast cancer9
Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 − negative subtype8
KRAS expression is a prognostic indicator and associated with immune infiltration in breast cancer8
Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan8
LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-2998
Optimal duration of endocrine therapy with extended aromatase inhibitors for postmenopausal patients with hormone receptor-positive breast cancer: a meta-analysis8
Clinical effects of assessing electronic patient-reported outcomes monitoring symptomatic toxicities during breast cancer therapy: a nationwide and population-based study8
Utility of urinary type I collagen cross-linked N-telopeptide as a prognostic indicator in breast cancer patients with bone metastases8
Differential expression of the BCAT isoforms between breast cancer subtypes7
Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population7
Subcellular localization of EZH2 phosphorylated at T367 stratifies metaplastic breast carcinoma subtypes7
Current status of breast cancer screening in high-risk women in Japan7
Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients7
Comparative evaluation of nuclear and histological grades as prognostic factors for invasive breast cancer7
Prognostic model based on six PD-1 expression and immune infiltration-associated genes predicts survival in breast cancer7
A novel immune-related prognostic index for predicting breast cancer overall survival7
Nationwide mammographic screening and breast cancer mortality in Taiwan: an interrupted time-series analysis7
PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing7
PAM50- and immunohistochemistry-based subtypes of breast cancer and their relationship with breast cancer mortality in a population-based study7
Association of lymphatic flow velocity with surgical outcomes in patients undergoing lymphovenous anastomosis for breast cancer-related lymphedema7
Detection of breast cancer precursor lesions by autofluorescence ductoscopy7
The associations of healthy lifestyle index with breast cancer incidence and mortality in a population-based study7
Kounis syndrome after patent blue dye injection for sentinel lymph node biopsy7
Perceived physical fatigability improves after an exercise intervention among breast cancer survivors: a randomized clinical trial7
LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF67
Discovery and function exploration of microRNA-155 as a molecular biomarker for early detection of breast cancer7
Diagnostic performance of dedicated breast positron emission tomography7
Surgical treatment trends and identification of primary breast tumors after surgery in occult breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry7
Can breast MRI and adjunctive Doppler ultrasound improve the accuracy of predicting pathological complete response after neoadjuvant chemotherapy?6
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B)6
Multispectral quantitative immunohistochemical analysis of tumor-infiltrating lymphocytes in relation to programmed death-ligand 1 expression in triple-negative breast cancer6
Sensitivity and specificity of screening mammography without clinical breast examination among Japanese women aged 40–49 years: analysis of data from the J-START results6
Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study6
Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis6
Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistance6
Comparing the extent of breast cancer tumors through contrast-enhanced ultrasound vs B-mode, opposed with pathology: evergreen study6
The effectiveness of moisturizer on acute radiation-induced dermatitis in breast cancer patients: a systematic review and meta-analysis6
Understanding breast cancer heterogeneity through non-genetic heterogeneity6
Sedentary behavior and risk of breast cancer: a dose–response meta-analysis from prospective studies6
HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC6
BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion6
Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer6
Psychometric properties of the SF-6Dv2 in an Iranian breast cancer population6
3-Dimensional objective aesthetic evaluation to replace panel assessment after breast-conserving treatment6
The impact of cognitive impairment on survival and medication adherence among older women with breast cancer6
Usefulness of new shear wave elastography in early predicting the efficacy of neoadjuvant chemotherapy for patients with breast cancer: where and when to measure is optimal?6
Trends in adjuvant therapy after breast-conserving surgery for ductal carcinoma in situ of breast: a retrospective cohort study using the National Breast Cancer Registry of Japan6
Current status of MRI-guided vacuum-assisted breast biopsy in Japan6
0.050235986709595